EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling

Peng Chen, Hang Zhou, Xian Yang, Yuzhen Zheng, Yujie Chen, Peiyuan Wang, Hao He, Shuoyan Liu, Feng Wang

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Peng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Receptor Tyrosine Kinase-like Orphan Receptors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by funding from the Science and Technology Program of Fujian Province (No. 2023J011263), the National Natural Science Foundation of Ch….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A‐to‐I RNA editing is a pervasive mechanism in the human genome that affects the regulation of gene expression and is closely associated with the pathogenesis of numerous diseases. This study elucidates the regulatory mechanism of A‐to‐I edited miR‐1304‐3p in esophageal squamous cell carcinoma (ESCC). Western blot, immunohistochemistry, and RT‐qPCR assays were employed to quantify protein and mRNA expression. Colony formation, Edu, wound healing, and Transwell assays were applied to determine miRNA function. Glycolysis was assessed using glucose uptake and lactate production assay. A dual‐luciferase reporter assay confirmed the downstream targets of miRNA, and a xenograft assay demonstrated the efficacy of the miRNA. The A‐to‐I RNA editing level of miR‐1304‐3p was observed to increase in KYSE180 and KYSE140 ESCC cells following ADAR1 treatment. Following A‐to‐I editing, the function of miR‐1304‐3p in ESCC progression underwent a reversal, shifting from carcinogenic to inhibitory. Wild‐type (WT) miR‐1304‐3p targets IRS1, whereas the edited version targets ROR2. The WT miR‐1304‐3p, but not the edited version, suppressed the expression and tumor‐suppressive effect of IRS1 in ESCC. Conversely, ROR2, a specific downstream target of the edited miR‐1304‐3p, acted as a tumor promoter in ESCC. Furthermore, A‐to‐I editing of miR‐1304‐3p can inhibit glycolysis and inactivate the Wnt5a/ROR2 signaling pathway in ESCC. A‐to‐I RNA editing alters the function of miR‐1304‐3p in ESCC by changing its target gene. The edited miR‐1304‐3p hinders the development of ESCC by inhibiting glycolysis and inactivating the Wnt5a/ROR2 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsReceptor Tyrosine Kinase-like Orphan ReceptorsWnt-5a ProteinHumansGlycolysisAnimalsMiceCell ProliferationGene Expression Regulation, NeoplasticCell Line, TumorSignal TransductionMice, NudeXenograft Model Antitumor AssaysMice, Inbred BALB CMaleFemaleInsulin Receptor Substrate Proteins

Stichwörter der Autor:innen

A‐to‐I RNA editingIRS1Wnt5a/ROR2 signalingesophageal squamous cell carcinomaglycolysismiR‐1304‐3p

Substanzen

MicroRNAsReceptor Tyrosine Kinase-like Orphan ReceptorsROR2 protein, humanWnt-5a ProteinWNT5A protein, humanIRS1 protein, humanInsulin Receptor Substrate Proteins

Autor:innen und Institutionen

  • Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
  • Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, China.
  • Department of Nephrology, Fujian Provincial Hospital South Branch, Fuzhou, China.
  • Department of Thoracic Surgery, Sixth Affiliated Hospital of Sun Yat-sen University, Guangdong, Guangzhou, P. R. China.

Förderung

  • This study was supported by funding from the Science and Technology Program of Fujian Province (No. 2023J011263), the National Natural Science Foundation of Ch…

Zitieren

APA

Chen, P., Zhou, H., Yang, X., Zheng, Y., Chen, Y., Wang, P., He, H., Liu, S., & Wang, F. (2025). A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23867

Vancouver

Chen P, Zhou H, Yang X, Zheng Y, Chen Y, Wang P, et al. A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23867

BibTeX
@article{Chen2025,
  author = {Chen, Peng and Zhou, Hang and Yang, Xian and Zheng, Yuzhen and Chen, Yujie and Wang, Peiyuan and He, Hao and Liu, Shuoyan and Wang, Feng},
  title = {A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23867}
}
Kostenlos starten →